MBCL-14. MOLECULAR GENETIS BIOMARKERS FOR PROGNISIS DEFINING IN MEDULLOBLASTOMA PATIENTS

Medulloblastoma, the most common CNS malignancy of childhood, is known for a significant clinical heterogeneity. The aim of the study was investigation of prognostic molecular-genetic biomarkers in Russian cohort of medulloblastoma patients. Molecular subgrouping was performed by gene expression pro...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Druy, Alexander, Yasko, Ludmila, Papusha, Ludmila, Supik, Zhanna, Valiakhmetova, Andgie, Nigmatullina, Leila, Konovalov, Dmitry, Olshanskaya, Yulia, Novichkova, Galina
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2018
Konular:
Abstracts
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012591/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.412
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller